The drug companies are temporarily suspending enrollment of new patients into clinical trials evaluating the new histone deacetylase inhibitor MGCD0103.
This voluntary precaution is being taken due to the observation of pericarditis or pericardial effusion (heart complications :() in 19 patients out of approximately 400 patients treated to date.
|All times are GMT -4. The time now is 01:21 AM.|
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2020, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org